Fundraising FoxTECregen
2 known investors
Find your way into TECregen
Sign up to see every warm intro you have to TECregen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TECregen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening. Its therapeutics target immune decline, cancer, and inflammatory disease.
Investors · 2
Frequently asked questions
- What does TECregen do?
- TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening. Its therapeutics target immune decline, cancer, and inflammatory disease.
- Who are TECregen's investors?
- TECregen's investors include Lifespan Vision Ventures, Boehringer Ingelheim Venture Fund.